Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR

International Journal of Cancer

Volumn 79, Issue 6, 1998, Pages 645-651

  Bostick, Peter J ^a   Huynh, Kelly T ^a   Sarantou, Terry ^a   Turner, Roderick R ^b   Qr, Karen ^a   Giuliano, Armando E ^a   Hoon, Dave S B ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b SAINT JOHN'S HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURGERY; CELL STRAIN MCF 7; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TISSUE SECTION;

BLOTTING, SOUTHERN; BREAST NEOPLASMS; EVALUATION STUDIES; FROZEN SECTIONS; HUMANS; LYMPHATIC METASTASIS; OLIGOPEPTIDES; PROTO-ONCOGENE PROTEINS C-MET; PROTOZOAN PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0031793996     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981218)79:6<645::AID-IJC16>3.0.CO;2-R     Document Type: Article

References (55)

1. BARRESI, G. and TUCCARI, G., Immunocytochemical demonstration of melanotransferrin (p97) in thyroid tumors of follicular cell origin. Pathology, 26, 127-129 (1994).
2. BEVIGLIA, L., MATSUMOTO, K., LIN, C., ZIOBER, B. and KRAMER, R., Expression of the c-Met/HGF receptor in breast carcinoma: correlation with tumor progression. Int. J. Cancer, 74, 301-309 (1997).
3. BIESTERFELD, S., VEUSKENS, U., SCHMITZ, F.Z., AMO-TAKYI, B. and BOCKING, A., Interobserver reproducibility of immunocytochemical estrogen and progesterone receptor status assessment in breast cancer. Anticancer Res., 16, 2497-2500 (1996).
4. BOSTICK, P.J., CHATTERJEE, S., CHI, D.D., HUYNH, K.T., GIULIANO, A.E., COTE, R. and HOON, D.S.B., Limitations of specific RT-PCR markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J. clin. Oncol. (1998). (In press).
5. BOUVET, M., OLLILA, D.W., HUNT, K.K., BABIERA, G.V., SPITZ, F.R., GIULIANO, A.E., STROM, E.A., AMES, F.C., Ross, M.I. and SINGLETARY, S.E., Role of conservation therapy for invasive lobular carcinoma of the breast. Ann. Surg. Oncol., 4, 650-654 (1997).
6. BRASSEUR, F. and 29 OTHERS, Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer, 63, 375-380 (1995).
7. BROOKS, S.A. and LEATHEM, A.J., Expression of alpha-GalNAc glycoproteins by breast cancers. Brit. J. Cancer, 71, 1033-1038 (1995).
8. BROWN, J.P., NISHIYAMA, K., HELLSTROM, I. and HELLSTROM, K.E., Structural characterization of human melanoma-associated antigen p97 using monoclonal antibodies. J. Immunol., 127, 539-546 (1981).
9. DATTA, Y.H., ADAMS, P.T., DROBYSKI, W.R., ETHIER, S.P., TERRY, V.H. and ROTH, M.S., Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. clin. Oncol., 12, 475-482 (1994).
10. DEAN, M., PARK, M., LE BEAU, M.M., ROBINS, T.S., DIAZ, M.O., ROWLEY, J.D., BLAIR, D.G. and VANDE WOUDE, G.F., The human met oncogene is related to the tyrosine kinase oncogenes. Nature, 318, 385-388 (1985).
11. DE LA ROCHEFORDIERE, A., MOURET-FOURME, E., ASSELAIN, B., SCHOLL, S.M., CAMPANA, F., BROET, P. and FOURQUET, A., Metachronous contralateral breast cancer as first event of relapse. Int. J. Radiat. Oncol. Biol. Phys., 36, 615-621 (1996).
12. DI RENZO, M., OLIVERO, M., KATSAROS, D., CREPALDI, T., GAGLIA, P., ZOLA, P., SISMONDI, P. and COMOGLIO, P., Over-expression of the Met/HGF receptor in ovarian cancer. Int. J. Cancer, 58, 658-662 (1994).
13. DI RENZO, M. and 12 OTHERS, Over-expression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer. Clin. Cancer Res., 1, 147-154 (1995).
14. FISHER, E.R., SWONIDOSS, S., LEE, C.H., ROCKETTE, H., REDMOND, C. and FISHER, B., Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer, 45, 2925-2931 (1978).
15. GHERARDI, E. and STOKER, M., Hepatocyte growth factor-scatter factor: mitogen, motogen, and met. Cancer Cells, 3, 227-232 (1991).
16. GIULIANO, A.E., DALE, P.S., TURNER, R.R. and MORTON, D.L., Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann. Surg., 222, 394-401 (1995).
17. GIULIANO, A.E., JONES, R.C., BRENNAN, M. and STATMAN, R., Sentinel lymphadenectomy in breast cancer. J. clin. Oncol., 15, 2345-2350 (1997).
18. GIULIANO, A.E., KIRGAN, D.M., GUENTHER, J.M. and MORTON, D.L., Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg., 220, 391-401 (1994).
19. HAKOMORI, S., Tumor malignancy denned by aberrant glycosylation and sphingo (glyco) lipid metabolism. Cancer Res., 56, 5309-5318 (1996).
20. HAWKINS, R.A., TESDALE, A.L., KILLEN, M.E., JACK, W.J., CHETTY, U., DIXON, J.M., HULME, M.J., PRESCOTT, R.J., MCINTYRE, M.A. and MILLER, W.R., Prospective evaluation of prognostic factors in operable breast cancer. Brit. J. Cancer, 74, 1469-1478 (1996).
21. HELLMAN, S., Natural history of small breast cancers. J. clin. Oncol., 12, 2229-2234 (1994).
22. HIROSE, K., TAJIMA, K., HAMAJIMA, N., KUROISHI, T., MIURA, S. and TOKUDOME, S., Impact of family history on the risk of breast cancer among the Japanese. Jpn. J. Cancer Res., 88, 1130-1136 (1997).
23. HOON, D., ANDO, I., SVILAND, G., TSUCHIDA, T., OUN, E., MORTON, D.L. and IRIE, R., Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells. Int. J. Cancer, 43, 857-862 (1989).
24. HOON, D., DOI, F., GIULIANO, A.E., SCHMID, P. and CONRAD, A.J., The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer, 76, 533-534 (1995a).
25. HOON, D., OKUN, E., NEUWIRTH, H., MORTON, D. and IRIE, R.F., Abberant expression of gangliosides in human renal cell carcinomas. J. Urol., 150, 2013-2018 (1993).
26. HOON, D., SARANTOU, T., DOI, F., CHI, D., KUO, C., CONRAD, A.J., SCHMID, P., TURNER, R. and GIULIANO, A.E., Detection of metastatic breast cancer by β-HCG polymerase chain reaction. Int. J. Cancer, 69, 369-374 (1996).
27. HOON, D., WANG, Y., DALE, P., CONRAD, A.J., SCHMID, P., GARRISON, D., KUO, C., FOSHAG, L.J., NIZZIE, A.J. and MORTON, D.L., Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J clin. Oncol., 13, 2109-2116 (1995b).
28. HURD, T.C., SNEIGE, N., ALLEN, P.K., STROM, E.A., MCNEESE, M.D., BABIERA, G.V. and SINGLETARY, S.E., Impact of extensive intraductal component on recurrence and survival in patients with stage I or II breast cancer treated with breast conservation therapy. Ann. surg. Oncol., 4, 119-124 (1997).
29. JOURA, E.A., LOSCH, A. KAINZ, C., SAM, C., JOURA, E.M., GITSCH, G., DADAK, C. and BREITENECKER, G., Infiltrating ductal carcinoma of the breast: extensive intraductal component has no impact on lymph node involvement and survival. Anticancer Res., 15, 2285-2286 (1995).
30. KUO, C., BOSTICK, P., IRIE, R., MORTON, D., CONRAD, A. and HOON, D.S.B., Assessment of β1 →4-N-acetyIgalactosaminyl-transferase as a molecular marker for metastatic melanoma. Clin. Cancer Res., 4, 411-418 (1998).
31. LUDWIG TRIAL, INTERNATIONAL BREAST CANCER STUDY GROUP, Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet, 335, 1565-1568 (1990).
32. MARIANI, L., CORADINI, D., BIGANZOLI, E., BORACCHI, P., MARUBINI, E., PILOTTI, S., SALVADORI, B., SILVESTRINI, R., VERONESI, U., ZUCALI, R. and RILKE, F., Prognostic factors for metachronous contralateral breast cancer: a comparison of the linear COX regression model and its artificial neural network extension. Breast Cancer Res. Treat., 44, 167-178 (1997).
33. MORI, M., MIMORI, K., INOUE, H., BARNARD, G.F., TSUJI, K., NABARA, S., UEO, H. and AKIYOSHI, T., Detection of cancer micrometastases in lymph nodes by reverse-transcriptase-polymerase chain reaction. Cancer Res., 55, 3417-3429 (1995).
34. MORTON, D.L., WEN, D.R., WONG, J.H., ECONOMOU, J.S., CAGLE, L.A., STORM, F.K., FOSHAG, L.J. and COCHRAN, A.J., Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg., 127, 392-399 (1992).
35. NAGATA, Y., YAMASHIRO, S., YODOI, J., LLOYD, K., SHIKU, H. and FURUKAWA, K., Expression cloning of β1 → 4-N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gansliosides. J. biol Chem., 267, 12082-12089 (1992).
36. NAGY, J., CURRY, G., HILLAN, K., MCKAY, I., MALLON, E., PURUSHOTHAM, A.D. and GEORGE, W.D., Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer. Surg. Oncol., 5, 15-21 (1996).
37. NARITA, M., NAKAO, K., OGINO, N., NAKAHARA, M., ONISHI, A. and TSUJIMOTO, M., Independent prognostic factors in breast cancer patients. Amer. J. Surg., 175, 73-75 (1998).
38. NATALI, P., NICOTRA, M., DI RENZO, M., PRAT, M., BIGOTTI, A., CAVALIERE, R. and COMOGLIO, P., Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumor progression. Brit. J. Cancer, 68, 746-750 (1993).
39. NIEZABITOWSKI, A., LACKOWSKA, B., GRUCHALA, A., RYS, J., JASZCZ, A., SZKLARSKI, W., WASILEWSKA, A. and HERMAN, K., Flow cytometric DNA-analysis of cells obtained with fine needle aspiration biopsy of the breast. Gen. Diagnostic Pathol., 142, 33-39 (1996).
40. NOGUCHI, S., AIHARA, T., MOTOMURA, K., INAJI, H., IMAOKA, S. and KOYAMA, H., Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Amer. J. Pathol., 148, 649-656 (1996).
41. OSINAGA, E., PANCINO, G., PORCHET, N., BEROIS, N., CREMOUX, P., MISTRO, D., AUBERT, J.P., CALVO, F. and ROSETO, A., Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant. Breast Cancer Res. Treat., 32, 139-152 (1994).
42. POHLENTZ, G., KLEIN, D., SCHWARZMANN, G., SCHMTTZ, D. and SANDHOFF, K., Both GA2, GM2, and GD2 sythetases and GM1b, GD1a, and GT1b synthases are single enzymes in Golgi vesicles from rat liver. Proc. nat. Acad. Sci. (Wash.), 85, 7044-7048 (1988).
43. PRESS, M.F. and 14 OTHERS, HER-2/Neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J. clin. Oncol., 15, 2894-2904 (1997).
44. QUIET, C.A., FERGUSON, D.J., WEICHSELBAUM, R.R. and HELLMAN, S., Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J. clin. Oncol., 13, 1144-1151 (1995).
45. RAHIMI, N., HALL, R., SAULNIER, R., NAKAMURA, T., PARK, M. and ELLIOT, B., Role of hepatocyte growth factor (HGF) in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA Cell Biol., 13, 1189-1197 (1994).
46. REMVIKOS, Y., MOSSERI, V., ASSELAIN, B., FOURQUET, A., DURAND, J.C., POUILLART, P. and MAGDELENAT, H., S-phase fractions of breast cancer predict overall and post-relapse survival. Europ. J. Cancer, 33, 581-586 (1997).
47. ROSE, T.M., PLOWMAN, G.D., TEPLOW, D.B., DREYER, W.J., HELLSTRÖM, K.E. and BROWN, J.P., Primary structure of the human melanoma-antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc. nat. Acad. Sci. (Wash.), 83, 1261-1265 (1986).
48. ROSEN, P.P., SAIGO, P.E., BRAUN, D.W., WEATHERS, E., FRACCHIA, A.A. and KINNE, D.W., Axillary micro- and macrometastases in breast cancer. Ann. Surg., 194, 585-591 (1981).
49. SARANTOU, T., CHI, D., GARRISON, D., CONRAD, A.J., SCHMID, R, MORTON, D.L. and HOON, D., Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res., 57, 1371-1376 (1997).
50. SCHOENFELD, A., LUQMANI, Y., SMITH, D., O'REILLY, S., SHOUSHA, S., SINNETT, H.D. and COMBES, R.C., Detection of breast cancer micrometastases by using polymerase chain reaction. Cancer Res., 54, 2986-2990 (1994).
51. TSARFATY, I., RESAU, J.H., RULONG, S., KEYDAR, I., FALETTO, D.L. and VANDE WOUDE, G.F., The Met proto-oncogene receptor and lumen formation. Science, 257, 1258-1261 (1992).
52. TUCK, A.B., PARK, M., STERNS, E.E., BOAG, A. and ELLIOT, B.E., Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Amer. J. Pathol., 148, 225-232 (1996).
53. TURNER, R.R., OLLILA, D.W., KRASNE, D.L. and GIULIANO, A., Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann. Surg., 226, 271-278 (1997).
54. UNIC, I., STALMEIER, P.F., PEER, P.G. and VAN DAAL, W.A., A review on family history of breast cancer: screening and counseling proposals for women with familial (non-hereditary) breast cancer. Patient Educ. Couns., 32, 117-127 (1997).
55. YAMASHIRO, S., RUAN, S., FURUKAWA, K., TAI, T., LLOYD, K.O., SHIKU, H. and FURUKAWA, K., Genetic and enyzmatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines. Cancer Res., 53, 5395-5400 (1993).